NYT: FDA Holding Off On Approving Plasma As Coronavirus Treatment
The FDA was set to emergency authorize the treatment, but top health officials said there isn't enough supporting data.
The FDA was set to emergency authorize the treatment, but top health officials said there isn't enough supporting data.